Security Snapshot

EASTMAN CHEMICAL CO - Common Stock (EMN) Institutional Ownership

CUSIP: 277432100

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

621

Shares (Excl. Options)

102,243,036

Price

$63.83

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
EMN on NYSE
Shares outstanding
114,454,368
Price per share
$74.25
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
102,243,036
Total reported value
$6,531,429,799
% of total 13F portfolios
0.01%
Share change
+2,234,478
Value change
+$145,837,344
Number of holders
621
Price from insider filings
$74.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • EMN - EASTMAN CHEMICAL CO - Common Stock is tracked under CUSIP 277432100.
  • 621 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 621 to 341 between Q4 2025 and Q1 2026.
  • Reported value moved from $6,531,429,799 to $2,849,193,250.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 621 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 277432100?
CUSIP 277432100 identifies EMN - EASTMAN CHEMICAL CO - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of EASTMAN CHEMICAL CO - Common Stock (EMN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% +16% $1,201,708,848 +$163,876,441 15,745,661 +16% BlackRock, Inc. 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 6.7% $585,406,073 7,670,415 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $455,975,214 5,974,518 Vanguard Capital Management 31 Mar 2026
FRANKLIN RESOURCES INC 3.9% -24% $360,609,223 -$107,423,355 4,493,013 -23% Franklin Resources, Inc. 30 Jun 2025
Capital Research Global Investors 3.7% -28% $340,807,476 -$131,648,150 4,246,293 -28% Capital Research Global Investors 30 Jun 2025

As of 31 Dec 2025, 621 institutional investors reported holding 102,243,036 shares of EASTMAN CHEMICAL CO - Common Stock (EMN). This represents 89% of the company’s total 114,454,368 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of EASTMAN CHEMICAL CO - Common Stock (EMN) together control 64% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 13,702,511 +72% 0.01% $874,631,250
VANGUARD GROUP INC 12% 13,272,165 -7.4% 0.01% $847,162,293
DIMENSIONAL FUND ADVISORS LP 4% 4,597,875 +13% 0.06% $293,485,711
STATE STREET CORP 3.4% 3,866,827 -32% 0.01% $250,073,355
Capital Research Global Investors 3.4% 3,855,729 -8.3% 0.05% $246,111,182
FRANKLIN RESOURCES INC 3.3% 3,722,964 +0.56% 0.06% $237,636,792
MORGAN STANLEY 2.9% 3,335,366 -13% 0.01% $212,896,516
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.3% 2,658,099 -4.1% 0.05% $169,666,459
EARNEST PARTNERS LLC 2.1% 2,405,649 +7.6% 0.66% $153,552,576
GEODE CAPITAL MANAGEMENT, LLC 1.7% 1,984,639 -36% 0.01% $126,723,309
BANK OF AMERICA CORP /DE/ 1.7% 1,977,352 +6.7% 0.01% $126,214,375
Allspring Global Investments Holdings, LLC 1.6% 1,859,998 +97% 0.19% $119,672,271
HighTower Advisors, LLC 1.5% 1,695,842 +3449% 0.12% $108,245,576
NORGES BANK 1.3% 1,498,065 0.01% $95,621,489
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.2% 1,425,806 +102% 0.05% $91,009,197
CITADEL ADVISORS LLC 1.2% 1,333,092 +26% 0.06% $85,091,262
LSV ASSET MANAGEMENT 1.1% 1,231,029 -2.7% 0.17% $78,577,000
Bank of New York Mellon Corp 1.1% 1,228,290 +3.6% 0.01% $78,401,755
LETKO, BROSSEAU & ASSOCIATES INC 1% 1,194,421 +5.5% 1.2% $76,239,892
Legal & General Group Plc 1% 1,169,318 +3.9% 0.02% $74,637,566
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.98% 1,121,551 -7.5% 0.01% $71,588,600
SEI INVESTMENTS CO 0.92% 1,057,353 +9.4% 0.07% $67,491,092
D. E. Shaw & Co., Inc. 0.9% 1,025,388 +129% 0.05% $65,450,516
Empower Advisory Group, LLC 0.83% 949,193 +4.3% 0.16% $60,586,969
NORTHERN TRUST CORP 0.81% 924,200 -20% 0.01% $58,991,686

Institutional Holders of EASTMAN CHEMICAL CO - Common Stock (EMN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 37,376,641 $2,849,193,250 +$182,570,835 $76.32 341
2025 Q4 102,243,036 $6,531,429,799 +$145,837,344 $63.83 621
2025 Q3 100,338,970 $6,329,380,256 -$271,714,583 $63.05 657
2025 Q2 103,861,221 $7,759,070,049 -$55,461,622 $74.66 743
2025 Q1 104,418,178 $9,198,335,354 -$94,733,769 $88.11 799
2024 Q4 105,331,807 $9,621,399,636 +$263,516,288 $91.32 778
2024 Q3 101,229,934 $11,332,054,600 +$14,917,286 $111.95 777
2024 Q2 101,491,593 $9,943,084,787 +$117,020,755 $97.97 748
2024 Q1 100,515,395 $10,072,615,583 +$654,165,314 $100.22 740
2023 Q4 98,094,417 $8,814,403,632 +$1,373,425 $89.82 707
2023 Q3 98,086,370 $7,527,480,278 -$74,520,802 $76.72 673
2023 Q2 98,854,076 $8,279,763,158 -$78,717,857 $83.72 688
2023 Q1 99,663,708 $8,407,239,756 -$3,826,799 $84.34 687
2022 Q4 100,313,548 $8,178,042,459 -$146,919,555 $81.44 696
2022 Q3 102,072,814 $7,260,851,267 -$307,758,657 $71.05 640
2022 Q2 104,719,636 $9,404,754,152 -$212,115,603 $89.77 673
2022 Q1 107,918,820 $12,088,340,149 -$612,845,017 $112.06 741
2021 Q4 112,749,559 $13,623,833,379 -$39,766,352 $120.91 743
2021 Q3 112,846,025 $11,368,373,603 -$134,082,637 $100.74 694
2021 Q2 114,107,039 $13,313,356,380 -$122,057,087 $116.75 716
2021 Q1 115,322,239 $12,693,892,757 +$26,071,665 $110.12 724
2020 Q4 115,200,428 $11,548,795,864 +$107,693,915 $100.28 685
2020 Q3 114,785,585 $8,953,976,823 +$226,987,987 $78.12 622
2020 Q2 111,518,521 $7,767,459,997 +$316,974,056 $69.64 597
2020 Q1 107,683,005 $5,020,904,197 -$297,035,980 $46.58 562
2019 Q4 112,176,715 $8,890,186,849 +$169,921,777 $79.26 636
2019 Q3 109,644,990 $8,096,759,418 -$213,135,438 $73.83 610
2019 Q2 112,371,503 $8,741,494,974 -$51,330,639 $77.83 622
2019 Q1 115,271,532 $8,746,645,214 +$51,209,109 $75.88 684
2018 Q4 114,916,921 $8,390,154,165 -$255,380,796 $73.11 676
2018 Q3 117,859,813 $11,255,216,314 -$182,220,921 $95.72 686
2018 Q2 119,677,024 $11,938,170,190 -$218,785,872 $99.96 717
2018 Q1 121,413,516 $12,788,586,499 -$36,262,315 $105.58 691
2017 Q4 122,356,147 $11,319,525,773 +$121,156,577 $92.64 684
2017 Q3 120,933,403 $10,937,665,875 +$88,962,522 $90.49 614
2017 Q2 120,104,260 $10,085,639,292 +$18,409,973 $83.99 607
2017 Q1 119,959,760 $9,692,435,201 +$800,984,475 $80.80 595
2016 Q4 119,785,038 $9,007,888,256 -$164,503,400 $75.21 602
2016 Q3 122,130,077 $8,259,550,060 -$226,745,393 $67.68 553
2016 Q2 125,731,608 $8,537,159,624 -$41,040,056 $67.90 565
2016 Q1 126,317,216 $9,121,182,164 +$320,615,654 $72.23 558
2015 Q4 122,967,397 $8,301,695,263 -$9,657,365 $67.51 547
2015 Q3 123,189,732 $7,975,140,466 -$32,268,068 $64.72 552
2015 Q2 123,855,666 $10,132,193,148 +$243,223,458 $81.82 555
2015 Q1 121,286,772 $8,401,896,804 -$77,695,029 $69.26 550
2014 Q4 122,220,307 $9,271,870,925 +$116,489,351 $75.86 564
2014 Q3 119,570,907 $9,672,489,912 -$146,731,675 $80.89 526
2014 Q2 121,041,519 $10,572,196,200 -$149,874,149 $87.35 554
2014 Q1 122,213,090 $10,535,192,643 -$249,638,740 $86.21 539
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .